Skip to content

Carpal Tunnel Syndrome Release Using PSU Retractor

Comparison Results of Carpal Tunnel Release Between Standard Incision and Limited Incision Using PSU Retractor: A Randomized Controlled Trial

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01017471
Enrollment
60
Registered
2009-11-20
Start date
2009-09-30
Completion date
2012-12-31
Last updated
2012-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome

Keywords

carpal tunnel syndrome, surgery, PSU retractor, carpal tunnel syndrome who failed to conservative treatment

Brief summary

The investigators study aims to evaluate both efficacy and safety of carpal tunnel release using limited incision with the PSU retractor compared to standard incision. The investigators will do a randomized controlled trial in 60 patients with carpal tunnel release and evaluate for outcome regarding pain, VAS score, return to work time, CTS score and complications at 6 months.

Interventions

PROCEDURELimited incision using PSU retractor

carpal tunnel release using limited incision with PSU retractor will be done by orthopaedic hand surgeons

Sponsors

Prince of Songkla University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
15 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed as carpal tunnel syndrome who failed to conservative treatment 3 months

Exclusion criteria

* Underlying disease such as : DM, neuropathy * Previous wrist or hand surgery in the same side * Previous wrist and hand trauma * Pregnancy

Design outcomes

Primary

MeasureTime frame
CTS score1 year

Secondary

MeasureTime frame
VAS score1 year
return to work time1 year
satisfaction score1 year
complication rate1 year

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026